Research Analysts’ downgrades for Friday, May 3rd:

Achillion Pharmaceuticals (NASDAQ:ACHN) was downgraded by analysts at Barclays PLC from an equal weight rating to an underweight rating.

Accenture (NYSE:ACN) was downgraded by analysts at Bank of America Corp from a buy rating to a neutral rating. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Brightsphere Investment Group (NYSE:BSIG) was downgraded by analysts at Evercore ISI to an outperform rating.

Cambrex (NYSE:CBM) was downgraded by analysts at Robert W. Baird from an outperform rating to a neutral rating.

Celgene (NASDAQ:CELG) was downgraded by analysts at Barclays PLC from an overweight rating to an equal weight rating. The firm currently has $102.00 target price on the stock.

Cigna (NYSE:CI) was downgraded by analysts at Goldman Sachs Group Inc from a conviction-buy rating to a buy rating.

Cott (NYSE:COT) (TSE:BCB) was downgraded by analysts at TD Securities to a buy rating.

Ctrip.Com International (NASDAQ:CTRP) was downgraded by analysts at Macquarie from an outperform rating to a neutral rating.

Cognizant Technology Solutions (NASDAQ:CTSH) was downgraded by analysts at Wedbush from an outperform rating to a neutral rating.

Cognizant Technology Solutions (NASDAQ:CTSH) was downgraded by analysts at Needham & Company LLC from a strong-buy rating to a hold rating.

Cognizant Technology Solutions (NASDAQ:CTSH) was downgraded by analysts at Goldman Sachs Group Inc from a buy rating to a neutral rating.

Cognizant Technology Solutions (NASDAQ:CTSH) was downgraded by analysts at Oppenheimer Holdings Inc. from an outperform rating to a market perform rating.

Cognizant Technology Solutions (NASDAQ:CTSH) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

Cognizant Technology Solutions (NASDAQ:CTSH) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating.

Bottomline Technologies (NASDAQ:EPAY) was downgraded by analysts at Raymond James to an outperform rating.

FARO Technologies (NASDAQ:FARO) was downgraded by analysts at Needham & Company LLC from a buy rating to a hold rating.

Fortinet (NASDAQ:FTNT) was downgraded by analysts at Citigroup Inc from a neutral rating to a sell rating.

Hilton Grand Vacations (NYSE:HGV) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. JPMorgan Chase & Co. currently has $30.00 price target on the stock.

Incyte (NASDAQ:INCY) was downgraded by analysts at Barclays PLC from an overweight rating to an equal weight rating. The firm currently has $82.00 target price on the stock, down from their previous target price of $90.00.

Janus Henderson Group (NYSE:JHG) was downgraded by analysts at Goldman Sachs Group Inc from a neutral rating to a sell rating.

KION GRP AG/ADR (OTCMKTS:KIGRY) was downgraded by analysts at Jefferies Financial Group Inc from a buy rating to a hold rating.

Monolithic Power Systems (NASDAQ:MPWR) was downgraded by analysts at Needham & Company LLC from a buy rating to a hold rating.

Oxford Square Capital (NASDAQ:OXSQ) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Oxford Square Capital Corp. is a business development company principally investing in syndicated bank loans and debt and equity tranches of CLO vehicles. Oxford Square Capital Corp., formerly known as TICC Capital Corp., is based in Greenwich, United States. “

Potlatchdeltic (NASDAQ:PCH) was downgraded by analysts at Zacks Investment Research from a buy rating to a strong sell rating. According to Zacks, “Potlatch Corporation is a Real Estate Investment Trust (REIT) with the acres of timberland in Alabama, Arkansas, Idaho, Minnesota and Mississippi. Potlatch, a certified forest practices leader, is committed to providing superior returns to stockholders through long-term stewardship of its forest resources. The company also conducts a land sales and development business and operates wood products manufacturing facilities through its taxable REIT subsidiary. “

PennantPark Investment (NASDAQ:PNNT) was downgraded by analysts at Compass Point from a buy rating to a neutral rating. Compass Point currently has $7.00 price target on the stock, down from their previous price target of $8.50.

Proto Labs (NYSE:PRLB) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Proto Labs, Inc. is an online and technology-enabled quick-turn manufacturer of custom parts for prototyping and short-run production. It produces CNC machined and injection molded plastic parts. Proto Labs targets their services to product developers who use three-dimensional computer-aided design to develop products across a diverse range of end-markets. The Company has locations in the United States, the United Kingdom, Germany, Japan, Italy, France, and Spain. Proto Labs, Inc. is headquartered in Maple Plain, Minnesota. “

Realogy (NYSE:RLGY) was downgraded by analysts at Compass Point from a neutral rating to a sell rating. The firm currently has $8.00 price target on the stock, down from their previous price target of $12.50.

Acceleron Pharma (NASDAQ:XLRN) was downgraded by analysts at Barclays PLC from an overweight rating to an equal weight rating. The firm currently has $45.00 target price on the stock, down from their previous target price of $54.00.

Yeti (NYSE:YETI) was downgraded by analysts at Goldman Sachs Group Inc from a buy rating to a neutral rating.

Receive News & Ratings for Achillion Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achillion Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.